Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Loss from continuing operations $ (1,109,323) $ (889,524)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations:    
Depreciation and amortization 132,774 281,272
Deferred income taxes (11,472) (25,787)
Noncash lease expense 22,847 22,847
Stock-based compensation expense 33,496 124,484
Litigation settlement reserve 16,789
Allowance for credit losses 8,816 (66,208)
Reduction of merchant reserve 190,000
Changes in operating assets and liabilities, net of effects of discontinued operations:    
Accounts receivable 176,276 361,178
Prepaid expenses and other current assets 119,604 (370,572)
Accounts payable 113,179 212,321
Accrued expenses (52,374) (182,547)
Lease liability (25,736) (25,123)
Deferred revenue 197,755 63,527
Net cash used in operating activities - continuing operations (394,158) (287,343)
Net cash used in operating activities - discontinued operations (29,607) (1,240)
Net cash used in operating activities (423,765) (288,583)
Cash flows from investing activities:    
Costs incurred to develop technology (29,801)
Purchases of property and equipment (1,920) (1,791)
Acquisition of assets of Expo Experts (400,000)
Additional acquisition of equity interest in RemoteMore USA, Inc. (116,667)
Net cash used in investing activities - continuing operations (548,388) (1,791)
Net cash used in investing activities (548,388) (1,791)
Cash flows from financing activities:    
Proceeds from the sale of common stock 700,000
Stock buyback plan (139,979)
Net cash provided by financing activities - continuing operations 700,000 (139,979)
Net cash provided by (used in) financing activities 700,000 (139,979)
Effect of exchange rate fluctuations on cash and cash equivalents (312) 1,242
Net decrease in cash and cash equivalents (272,465) (429,111)
Cash, cash equivalents, beginning of period 1,236,771 3,402,697
Cash and cash equivalents, end of period 964,306 2,973,586
Supplemental disclosures of other cash flow information:    
Non-cash stock issuance 200,000 400,000
Cash paid for income taxes